• Sonova has reported fiscal year sales of CHF3.63 billion, a decrease of 3% compared to the previous year.
• The sales revenue is in line with the estimated CHF3.66 billion.
• The organisation has declared a dividend per share of CHF4.30.
• The basic earnings per share (EPS) stand at CHF10.08.
• Adjusted Ebita is registered to be CHF771.4 million, a reduction of 8.2% from the previous year,
• This adjusted Ebita is approximately equal to the anticipated figure of CHF772.7 million.
• Currently, the company’s position in the market is evaluated as ‘9 buys, 10 holds, 3 sells’.
A look at Sonova Holding Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 2 | |
| Dividend | 3 | |
| Growth | 4 | |
| Resilience | 3 | |
| Momentum | 5 | |
| OVERALL SMART SCORE | 3.4 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Sonova Holding AG, a leading provider of hearing care solutions, is positioned for promising long-term growth based on the Smartkarma Smart Scores. With a Growth score of 4, the company is showing positive signs of expansion opportunities in the market. Additionally, Sonova Holding’s Momentum score of 5 suggests strong upward trends, indicating potential for continued success in the future.
While Sonova Holding may not be considered a high-value investment with a Value score of 2, its overall Resilience score of 3 reflects a stable and enduring business model. Coupled with a Dividend score of 3, investors can expect a moderate level of dividend payouts, providing additional incentive for long-term holding.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
